PARIS--(BUSINESS WIRE)--Neovacs, a biotech company pioneering the development of anti-cytokine and anti-viral regulation protein therapeutic vaccines, today announced the publication of an article on anti-IFNa kinoid active immunization in the March 11th edition of the prestigious journal PNAS (the Proceedings of the National Academy of Sciences of the USA). The integral press release is available by cliquing on the link.
